Plethysmograph Market size was valued at USD 103.1 Million in 2023 and is poised to cross USD 199.27 Million by the end of 2036, registering more than 5.2% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of plethysmograph is estimated at USD 107.93 Million. The growth of the market can be attributed to the increasing prevalence of chronic respiratory diseases, such as asthma and COPD, as well as the growing demand for accurate diagnosis of respiratory diseases. As of 2019, chronic respiratory diseases accounted for 534,242 deaths in North America, with 50% of deaths occurring in men and 50% in women. The mortality rate among men (42.2 deaths per 100,000) was higher than the mortality rate among women (31.0 deaths per 100,000). Plethysmographs are used to measure the volume of air in the lungs, as well as the amount of oxygen that is inhaled and exhaled. As the prevalence of respiratory diseases increases, the need for more accurate and reliable measurement of air volume and oxygen levels also increases, driving up the market growth.
In addition to these, factors that are believed to fuel the market growth of plethysmographs include growing awareness about health and well-being, increasing prevalence of lifestyle diseases, rising demand for non-invasive and painless diagnostic procedures, Moreover, technological advances in medical devices enable the development of next-generation plethysmographs, which is projected to drive market growth in coming years. For instance, COSMED's Q-Box is an advanced body box designed to accurately measure thoracic gas volume, including static lung volume (TLC, RV, and ITGV) and airway resistance and conductance (RAW and GAW) using complete body plethysmography.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
5.2% |
|
Base Year Market Size (2023) |
USD 103.1 Million |
|
Forecast Year Market Size (2036) |
USD 199.27 Million |
|
Regional Scope |
|
End-user (Hospitals, Clinics)
The global plethysmograph market is segmented and analyzed for demand and supply by end use into hospitals, clinics, and others. Out of these, the hospital segment is estimated to gain the largest market share of about 45% in the year 2036. The growth of the segment can be attributed to the rising number of hospital-based procedures, the increasing prevalence of chronic diseases, and technological advancements in plethysmograph devices are some of the factors driving the growth of the hospital segment. Additionally, government initiatives to promote the use of medical devices in healthcare facilities is further augmenting the market growth. For instance, the Government of India has initiated a program known as the National Health Mission, which is designed to provide free diagnostic services in hospitals with the help of noninvasive and low-cost tools to improve patients’ clinical outcomes.
Type (Body, Limbs)
The global market is segmented and analyzed for demand and supply by type into body plethysmograph, limb plethysmograph, and others. Out of these, the limb plethysmograph segment is estimated to gain a significant market share of about 38% in the year 2036. The growth of the segment can be attributed to the increasing prevalence of chronic illnesses such as hypertension and diabetes, which require frequent monitoring of limb volume. The limb plethysmograph is a non-invasive device that can measure the amount of blood flow in the limbs, which is important for monitoring hypertension and diabetes. Additionally, advancements in technology have made plethysmographs more accurate and user-friendly, and market players are launching products with these features, which is boosting the demand for plethysmographs.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Application |
|
|
By End Use |
|
North American Market Forecast
The market share of plethysmograph in North America, amongst the market in all the other regions, is projected to be the largest with a share of about 35% by the end of 2036. The growth of the market can be attributed majorly to the increasing awareness of the importance of preventive healthcare, and rising incidences of lung diseases such as asthma. According to the Asthma and Allergy Foundation of America, in the U.S., nearly 26 million people suffer from asthma and nearly 21 million Americans ages 18 and older suffer from asthma. In 2020, approximately 52.9% of children under the age of 5 suffering from asthma had an asthma attack. Asthma is a chronic lung disease that causes breathing difficulties and wheezing. The use of a plethysmograph allows doctors to measure the amount of air that a person can breathe in and out, which is helpful in diagnosing and monitoring asthma. In addition, advancements in connected healthcare technologies and the growing adoption of digital health solutions along with increasing demand for remote patient monitoring among regional populations are also driving the growth of the market in North America.
APAC Market Statistics
The Asia Pacific plethysmograph market is estimated to be the second largest, registering a share of about ~27% by the end of 2036. The growth of the market can be attributed majorly to the rising demand for ambulatory monitoring systems and the increasing prevalence of obesity as a result of sedentary lifestyles among the regional population. Obesity can contribute to a number of health issues such as cardiovascular diseases and respiratory problems, which in turn increases the demand for medical care and monitoring. Plethysmographs are used to monitor pulmonary function and are therefore in high demand in the Asia Pacific region attributable to the rising number of obese individuals. Additionally, increasing awareness about the advantages of plethysmograph testing and the availability of cost-effective plethysmograph systems in the region are also expected to drive market growth in the region.
Europe Market Forecast
Further, the plethysmograph market in Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2036. The growth of the market can be attributed majorly to the rising awareness about the benefits of the plethysmograph, the growing demand for technologically advanced medical devices, and the increasing demand for non-invasive diagnostic procedures. The growing number of people addicted to liquor and Smoking is also contributing to product demand in the region. Alcohol and smoking damage the lungs, making them more vulnerable to infection and diseases. This increases the need for accurate and reliable diagnostic tools, such as plethysmographs, to detect and diagnose respiratory problems.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?